Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality

Research output: Contribution to journalLetterResearchpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)9-10
Number of pages2
JournalThe Lancet Respiratory Medicine
Volume2
Issue number7
DOIs
Publication statusPublished - 2014

Cite this

@article{f112e18a060f4e3a9c761bde2a394951,
title = "Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality",
author = "Mark Jones and {Del Mar}, Chris and Rokuro Hama",
year = "2014",
doi = "10.1016/S2213-2600(14)70126-2",
language = "English",
volume = "2",
pages = "9--10",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2619",
publisher = "Elsevier",
number = "7",

}

Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality. / Jones, Mark; Del Mar, Chris; Hama, Rokuro.

In: The Lancet Respiratory Medicine, Vol. 2, No. 7, 2014, p. 9-10.

Research output: Contribution to journalLetterResearchpeer-review

TY - JOUR

T1 - Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality

AU - Jones, Mark

AU - Del Mar, Chris

AU - Hama, Rokuro

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84903943315&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(14)70126-2

DO - 10.1016/S2213-2600(14)70126-2

M3 - Letter

VL - 2

SP - 9

EP - 10

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

SN - 2213-2619

IS - 7

ER -